[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Active Pharmaceutical Ingredient(API) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

March 2023 | 118 pages | ID: G081EB5376F8EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Active Pharmaceutical Ingredient(API) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product (tablet, capsule, cream, injectable) that produces the intended effects.

This report is a detailed and comprehensive analysis for global Active Pharmaceutical Ingredient(API) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Active Pharmaceutical Ingredient(API) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Active Pharmaceutical Ingredient(API) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Active Pharmaceutical Ingredient(API) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Active Pharmaceutical Ingredient(API) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Active Pharmaceutical Ingredient(API)

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Active Pharmaceutical Ingredient(API) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceuticals, Pfizer, Aurobindo Pharma, Sun Pharmaceutical Industries Ltd. and Novartis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Active Pharmaceutical Ingredient(API) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • Generic API
  • Innovative API
Market segment by Application
  • Oncology
  • Cardiology
  • Cns and Neurology
  • Orthopaedic
  • Pulmonology
  • Gastroenterology
  • Nephrology
  • Ophthalmology
  • Endocrinology
Major players covered
  • Teva Pharmaceuticals
  • Pfizer
  • Aurobindo Pharma
  • Sun Pharmaceutical Industries Ltd.
  • Novartis
  • Mylan
  • Boehringer Ingelheim
  • Merck&Co.
  • AbbVie
  • Biocon
  • Bristol Myers Squibb
  • C.H.Boehringer Sohn AG&Co.KG
  • Cipla
  • Albemarle Corporation
  • Viatris
  • Dr. Reddy's Laboratories
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Active Pharmaceutical Ingredient(API) product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Active Pharmaceutical Ingredient(API), with price, sales, revenue and global market share of Active Pharmaceutical Ingredient(API) from 2018 to 2023.

Chapter 3, the Active Pharmaceutical Ingredient(API) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Active Pharmaceutical Ingredient(API) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Active Pharmaceutical Ingredient(API) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Active Pharmaceutical Ingredient(API).

Chapter 14 and 15, to describe Active Pharmaceutical Ingredient(API) sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Active Pharmaceutical Ingredient(API)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Active Pharmaceutical Ingredient(API) Consumption Value by Type: 2018 Versus 2022 Versus 2029
  1.3.2 Generic API
  1.3.3 Innovative API
1.4 Market Analysis by Application
  1.4.1 Overview: Global Active Pharmaceutical Ingredient(API) Consumption Value by Application: 2018 Versus 2022 Versus 2029
  1.4.2 Oncology
  1.4.3 Cardiology
  1.4.4 Cns and Neurology
  1.4.5 Orthopaedic
  1.4.6 Pulmonology
  1.4.7 Gastroenterology
  1.4.8 Nephrology
  1.4.9 Ophthalmology
  1.4.10 Endocrinology
1.5 Global Active Pharmaceutical Ingredient(API) Market Size & Forecast
  1.5.1 Global Active Pharmaceutical Ingredient(API) Consumption Value (2018 & 2022 & 2029)
  1.5.2 Global Active Pharmaceutical Ingredient(API) Sales Quantity (2018-2029)
  1.5.3 Global Active Pharmaceutical Ingredient(API) Average Price (2018-2029)

2 MANUFACTURERS PROFILES

2.1 Teva Pharmaceuticals
  2.1.1 Teva Pharmaceuticals Details
  2.1.2 Teva Pharmaceuticals Major Business
  2.1.3 Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Product and Services
  2.1.4 Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.1.5 Teva Pharmaceuticals Recent Developments/Updates
2.2 Pfizer
  2.2.1 Pfizer Details
  2.2.2 Pfizer Major Business
  2.2.3 Pfizer Active Pharmaceutical Ingredient(API) Product and Services
  2.2.4 Pfizer Active Pharmaceutical Ingredient(API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.2.5 Pfizer Recent Developments/Updates
2.3 Aurobindo Pharma
  2.3.1 Aurobindo Pharma Details
  2.3.2 Aurobindo Pharma Major Business
  2.3.3 Aurobindo Pharma Active Pharmaceutical Ingredient(API) Product and Services
  2.3.4 Aurobindo Pharma Active Pharmaceutical Ingredient(API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.3.5 Aurobindo Pharma Recent Developments/Updates
2.4 Sun Pharmaceutical Industries Ltd.
  2.4.1 Sun Pharmaceutical Industries Ltd. Details
  2.4.2 Sun Pharmaceutical Industries Ltd. Major Business
  2.4.3 Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Product and Services
  2.4.4 Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.4.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
2.5 Novartis
  2.5.1 Novartis Details
  2.5.2 Novartis Major Business
  2.5.3 Novartis Active Pharmaceutical Ingredient(API) Product and Services
  2.5.4 Novartis Active Pharmaceutical Ingredient(API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.5.5 Novartis Recent Developments/Updates
2.6 Mylan
  2.6.1 Mylan Details
  2.6.2 Mylan Major Business
  2.6.3 Mylan Active Pharmaceutical Ingredient(API) Product and Services
  2.6.4 Mylan Active Pharmaceutical Ingredient(API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.6.5 Mylan Recent Developments/Updates
2.7 Boehringer Ingelheim
  2.7.1 Boehringer Ingelheim Details
  2.7.2 Boehringer Ingelheim Major Business
  2.7.3 Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Product and Services
  2.7.4 Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.7.5 Boehringer Ingelheim Recent Developments/Updates
2.8 Merck&Co.
  2.8.1 Merck&Co. Details
  2.8.2 Merck&Co. Major Business
  2.8.3 Merck&Co. Active Pharmaceutical Ingredient(API) Product and Services
  2.8.4 Merck&Co. Active Pharmaceutical Ingredient(API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.8.5 Merck&Co. Recent Developments/Updates
2.9 AbbVie
  2.9.1 AbbVie Details
  2.9.2 AbbVie Major Business
  2.9.3 AbbVie Active Pharmaceutical Ingredient(API) Product and Services
  2.9.4 AbbVie Active Pharmaceutical Ingredient(API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.9.5 AbbVie Recent Developments/Updates
2.10 Biocon
  2.10.1 Biocon Details
  2.10.2 Biocon Major Business
  2.10.3 Biocon Active Pharmaceutical Ingredient(API) Product and Services
  2.10.4 Biocon Active Pharmaceutical Ingredient(API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.10.5 Biocon Recent Developments/Updates
2.11 Bristol Myers Squibb
  2.11.1 Bristol Myers Squibb Details
  2.11.2 Bristol Myers Squibb Major Business
  2.11.3 Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Product and Services
  2.11.4 Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.11.5 Bristol Myers Squibb Recent Developments/Updates
2.12 C.H.Boehringer Sohn AG&Co.KG
  2.12.1 C.H.Boehringer Sohn AG&Co.KG Details
  2.12.2 C.H.Boehringer Sohn AG&Co.KG Major Business
  2.12.3 C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Product and Services
  2.12.4 C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.12.5 C.H.Boehringer Sohn AG&Co.KG Recent Developments/Updates
2.13 Cipla
  2.13.1 Cipla Details
  2.13.2 Cipla Major Business
  2.13.3 Cipla Active Pharmaceutical Ingredient(API) Product and Services
  2.13.4 Cipla Active Pharmaceutical Ingredient(API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.13.5 Cipla Recent Developments/Updates
2.14 Albemarle Corporation
  2.14.1 Albemarle Corporation Details
  2.14.2 Albemarle Corporation Major Business
  2.14.3 Albemarle Corporation Active Pharmaceutical Ingredient(API) Product and Services
  2.14.4 Albemarle Corporation Active Pharmaceutical Ingredient(API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.14.5 Albemarle Corporation Recent Developments/Updates
2.15 Viatris
  2.15.1 Viatris Details
  2.15.2 Viatris Major Business
  2.15.3 Viatris Active Pharmaceutical Ingredient(API) Product and Services
  2.15.4 Viatris Active Pharmaceutical Ingredient(API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.15.5 Viatris Recent Developments/Updates
2.16 Dr. Reddy's Laboratories
  2.16.1 Dr. Reddy's Laboratories Details
  2.16.2 Dr. Reddy's Laboratories Major Business
  2.16.3 Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Product and Services
  2.16.4 Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.16.5 Dr. Reddy's Laboratories Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: ACTIVE PHARMACEUTICAL INGREDIENT(API) BY MANUFACTURER

3.1 Global Active Pharmaceutical Ingredient(API) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Active Pharmaceutical Ingredient(API) Revenue by Manufacturer (2018-2023)
3.3 Global Active Pharmaceutical Ingredient(API) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
  3.4.1 Producer Shipments of Active Pharmaceutical Ingredient(API) by Manufacturer Revenue ($MM) and Market Share (%): 2022
  3.4.2 Top 3 Active Pharmaceutical Ingredient(API) Manufacturer Market Share in 2022
  3.4.2 Top 6 Active Pharmaceutical Ingredient(API) Manufacturer Market Share in 2022
3.5 Active Pharmaceutical Ingredient(API) Market: Overall Company Footprint Analysis
  3.5.1 Active Pharmaceutical Ingredient(API) Market: Region Footprint
  3.5.2 Active Pharmaceutical Ingredient(API) Market: Company Product Type Footprint
  3.5.3 Active Pharmaceutical Ingredient(API) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Active Pharmaceutical Ingredient(API) Market Size by Region
  4.1.1 Global Active Pharmaceutical Ingredient(API) Sales Quantity by Region (2018-2029)
  4.1.2 Global Active Pharmaceutical Ingredient(API) Consumption Value by Region (2018-2029)
  4.1.3 Global Active Pharmaceutical Ingredient(API) Average Price by Region (2018-2029)
4.2 North America Active Pharmaceutical Ingredient(API) Consumption Value (2018-2029)
4.3 Europe Active Pharmaceutical Ingredient(API) Consumption Value (2018-2029)
4.4 Asia-Pacific Active Pharmaceutical Ingredient(API) Consumption Value (2018-2029)
4.5 South America Active Pharmaceutical Ingredient(API) Consumption Value (2018-2029)
4.6 Middle East and Africa Active Pharmaceutical Ingredient(API) Consumption Value (2018-2029)

5 MARKET SEGMENT BY TYPE

5.1 Global Active Pharmaceutical Ingredient(API) Sales Quantity by Type (2018-2029)
5.2 Global Active Pharmaceutical Ingredient(API) Consumption Value by Type (2018-2029)
5.3 Global Active Pharmaceutical Ingredient(API) Average Price by Type (2018-2029)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Active Pharmaceutical Ingredient(API) Sales Quantity by Application (2018-2029)
6.2 Global Active Pharmaceutical Ingredient(API) Consumption Value by Application (2018-2029)
6.3 Global Active Pharmaceutical Ingredient(API) Average Price by Application (2018-2029)

7 NORTH AMERICA

7.1 North America Active Pharmaceutical Ingredient(API) Sales Quantity by Type (2018-2029)
7.2 North America Active Pharmaceutical Ingredient(API) Sales Quantity by Application (2018-2029)
7.3 North America Active Pharmaceutical Ingredient(API) Market Size by Country
  7.3.1 North America Active Pharmaceutical Ingredient(API) Sales Quantity by Country (2018-2029)
  7.3.2 North America Active Pharmaceutical Ingredient(API) Consumption Value by Country (2018-2029)
  7.3.3 United States Market Size and Forecast (2018-2029)
  7.3.4 Canada Market Size and Forecast (2018-2029)
  7.3.5 Mexico Market Size and Forecast (2018-2029)

8 EUROPE

8.1 Europe Active Pharmaceutical Ingredient(API) Sales Quantity by Type (2018-2029)
8.2 Europe Active Pharmaceutical Ingredient(API) Sales Quantity by Application (2018-2029)
8.3 Europe Active Pharmaceutical Ingredient(API) Market Size by Country
  8.3.1 Europe Active Pharmaceutical Ingredient(API) Sales Quantity by Country (2018-2029)
  8.3.2 Europe Active Pharmaceutical Ingredient(API) Consumption Value by Country (2018-2029)
  8.3.3 Germany Market Size and Forecast (2018-2029)
  8.3.4 France Market Size and Forecast (2018-2029)
  8.3.5 United Kingdom Market Size and Forecast (2018-2029)
  8.3.6 Russia Market Size and Forecast (2018-2029)
  8.3.7 Italy Market Size and Forecast (2018-2029)

9 ASIA-PACIFIC

9.1 Asia-Pacific Active Pharmaceutical Ingredient(API) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Active Pharmaceutical Ingredient(API) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Active Pharmaceutical Ingredient(API) Market Size by Region
  9.3.1 Asia-Pacific Active Pharmaceutical Ingredient(API) Sales Quantity by Region (2018-2029)
  9.3.2 Asia-Pacific Active Pharmaceutical Ingredient(API) Consumption Value by Region (2018-2029)
  9.3.3 China Market Size and Forecast (2018-2029)
  9.3.4 Japan Market Size and Forecast (2018-2029)
  9.3.5 Korea Market Size and Forecast (2018-2029)
  9.3.6 India Market Size and Forecast (2018-2029)
  9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
  9.3.8 Australia Market Size and Forecast (2018-2029)

10 SOUTH AMERICA

10.1 South America Active Pharmaceutical Ingredient(API) Sales Quantity by Type (2018-2029)
10.2 South America Active Pharmaceutical Ingredient(API) Sales Quantity by Application (2018-2029)
10.3 South America Active Pharmaceutical Ingredient(API) Market Size by Country
  10.3.1 South America Active Pharmaceutical Ingredient(API) Sales Quantity by Country (2018-2029)
  10.3.2 South America Active Pharmaceutical Ingredient(API) Consumption Value by Country (2018-2029)
  10.3.3 Brazil Market Size and Forecast (2018-2029)
  10.3.4 Argentina Market Size and Forecast (2018-2029)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Active Pharmaceutical Ingredient(API) Market Size by Country
  11.3.1 Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Quantity by Country (2018-2029)
  11.3.2 Middle East & Africa Active Pharmaceutical Ingredient(API) Consumption Value by Country (2018-2029)
  11.3.3 Turkey Market Size and Forecast (2018-2029)
  11.3.4 Egypt Market Size and Forecast (2018-2029)
  11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
  11.3.6 South Africa Market Size and Forecast (2018-2029)

12 MARKET DYNAMICS

12.1 Active Pharmaceutical Ingredient(API) Market Drivers
12.2 Active Pharmaceutical Ingredient(API) Market Restraints
12.3 Active Pharmaceutical Ingredient(API) Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
  12.5.1 Influence of COVID-19
  12.5.2 Influence of Russia-Ukraine War

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Active Pharmaceutical Ingredient(API) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Active Pharmaceutical Ingredient(API)
13.3 Active Pharmaceutical Ingredient(API) Production Process
13.4 Active Pharmaceutical Ingredient(API) Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Active Pharmaceutical Ingredient(API) Typical Distributors
14.3 Active Pharmaceutical Ingredient(API) Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Active Pharmaceutical Ingredient(API) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Active Pharmaceutical Ingredient(API) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Teva Pharmaceuticals Major Business
Table 5. Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Product and Services
Table 6. Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Teva Pharmaceuticals Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Active Pharmaceutical Ingredient(API) Product and Services
Table 11. Pfizer Active Pharmaceutical Ingredient(API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Pfizer Recent Developments/Updates
Table 13. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Aurobindo Pharma Major Business
Table 15. Aurobindo Pharma Active Pharmaceutical Ingredient(API) Product and Services
Table 16. Aurobindo Pharma Active Pharmaceutical Ingredient(API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Aurobindo Pharma Recent Developments/Updates
Table 18. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 19. Sun Pharmaceutical Industries Ltd. Major Business
Table 20. Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Product and Services
Table 21. Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Active Pharmaceutical Ingredient(API) Product and Services
Table 26. Novartis Active Pharmaceutical Ingredient(API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Novartis Recent Developments/Updates
Table 28. Mylan Basic Information, Manufacturing Base and Competitors
Table 29. Mylan Major Business
Table 30. Mylan Active Pharmaceutical Ingredient(API) Product and Services
Table 31. Mylan Active Pharmaceutical Ingredient(API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Mylan Recent Developments/Updates
Table 33. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 34. Boehringer Ingelheim Major Business
Table 35. Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Product and Services
Table 36. Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Boehringer Ingelheim Recent Developments/Updates
Table 38. Merck&Co. Basic Information, Manufacturing Base and Competitors
Table 39. Merck&Co. Major Business
Table 40. Merck&Co. Active Pharmaceutical Ingredient(API) Product and Services
Table 41. Merck&Co. Active Pharmaceutical Ingredient(API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Merck&Co. Recent Developments/Updates
Table 43. AbbVie Basic Information, Manufacturing Base and Competitors
Table 44. AbbVie Major Business
Table 45. AbbVie Active Pharmaceutical Ingredient(API) Product and Services
Table 46. AbbVie Active Pharmaceutical Ingredient(API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. AbbVie Recent Developments/Updates
Table 48. Biocon Basic Information, Manufacturing Base and Competitors
Table 49. Biocon Major Business
Table 50. Biocon Active Pharmaceutical Ingredient(API) Product and Services
Table 51. Biocon Active Pharmaceutical Ingredient(API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Biocon Recent Developments/Updates
Table 53. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 54. Bristol Myers Squibb Major Business
Table 55. Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Product and Services
Table 56. Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Bristol Myers Squibb Recent Developments/Updates
Table 58. C.H.Boehringer Sohn AG&Co.KG Basic Information, Manufacturing Base and Competitors
Table 59. C.H.Boehringer Sohn AG&Co.KG Major Business
Table 60. C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Product and Services
Table 61. C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. C.H.Boehringer Sohn AG&Co.KG Recent Developments/Updates
Table 63. Cipla Basic Information, Manufacturing Base and Competitors
Table 64. Cipla Major Business
Table 65. Cipla Active Pharmaceutical Ingredient(API) Product and Services
Table 66. Cipla Active Pharmaceutical Ingredient(API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Cipla Recent Developments/Updates
Table 68. Albemarle Corporation Basic Information, Manufacturing Base and Competitors
Table 69. Albemarle Corporation Major Business
Table 70. Albemarle Corporation Active Pharmaceutical Ingredient(API) Product and Services
Table 71. Albemarle Corporation Active Pharmaceutical Ingredient(API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Albemarle Corporation Recent Developments/Updates
Table 73. Viatris Basic Information, Manufacturing Base and Competitors
Table 74. Viatris Major Business
Table 75. Viatris Active Pharmaceutical Ingredient(API) Product and Services
Table 76. Viatris Active Pharmaceutical Ingredient(API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Viatris Recent Developments/Updates
Table 78. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 79. Dr. Reddy's Laboratories Major Business
Table 80. Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Product and Services
Table 81. Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Dr. Reddy's Laboratories Recent Developments/Updates
Table 83. Global Active Pharmaceutical Ingredient(API) Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 84. Global Active Pharmaceutical Ingredient(API) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Active Pharmaceutical Ingredient(API) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 86. Market Position of Manufacturers in Active Pharmaceutical Ingredient(API), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Active Pharmaceutical Ingredient(API) Production Site of Key Manufacturer
Table 88. Active Pharmaceutical Ingredient(API) Market: Company Product Type Footprint
Table 89. Active Pharmaceutical Ingredient(API) Market: Company Product Application Footprint
Table 90. Active Pharmaceutical Ingredient(API) New Market Entrants and Barriers to Market Entry
Table 91. Active Pharmaceutical Ingredient(API) Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Active Pharmaceutical Ingredient(API) Sales Quantity by Region (2018-2023) & (K Units)
Table 93. Global Active Pharmaceutical Ingredient(API) Sales Quantity by Region (2024-2029) & (K Units)
Table 94. Global Active Pharmaceutical Ingredient(API) Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Active Pharmaceutical Ingredient(API) Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Active Pharmaceutical Ingredient(API) Average Price by Region (2018-2023) & (US$/Unit)
Table 97. Global Active Pharmaceutical Ingredient(API) Average Price by Region (2024-2029) & (US$/Unit)
Table 98. Global Active Pharmaceutical Ingredient(API) Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Global Active Pharmaceutical Ingredient(API) Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Global Active Pharmaceutical Ingredient(API) Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Active Pharmaceutical Ingredient(API) Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Active Pharmaceutical Ingredient(API) Average Price by Type (2018-2023) & (US$/Unit)
Table 103. Global Active Pharmaceutical Ingredient(API) Average Price by Type (2024-2029) & (US$/Unit)
Table 104. Global Active Pharmaceutical Ingredient(API) Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Global Active Pharmaceutical Ingredient(API) Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Global Active Pharmaceutical Ingredient(API) Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Active Pharmaceutical Ingredient(API) Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Active Pharmaceutical Ingredient(API) Average Price by Application (2018-2023) & (US$/Unit)
Table 109. Global Active Pharmaceutical Ingredient(API) Average Price by Application (2024-2029) & (US$/Unit)
Table 110. North America Active Pharmaceutical Ingredient(API) Sales Quantity by Type (2018-2023) & (K Units)
Table 111. North America Active Pharmaceutical Ingredient(API) Sales Quantity by Type (2024-2029) & (K Units)
Table 112. North America Active Pharmaceutical Ingredient(API) Sales Quantity by Application (2018-2023) & (K Units)
Table 113. North America Active Pharmaceutical Ingredient(API) Sales Quantity by Application (2024-2029) & (K Units)
Table 114. North America Active Pharmaceutical Ingredient(API) Sales Quantity by Country (2018-2023) & (K Units)
Table 115. North America Active Pharmaceutical Ingredient(API) Sales Quantity by Country (2024-2029) & (K Units)
Table 116. North America Active Pharmaceutical Ingredient(API) Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Active Pharmaceutical Ingredient(API) Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Active Pharmaceutical Ingredient(API) Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Europe Active Pharmaceutical Ingredient(API) Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Europe Active Pharmaceutical Ingredient(API) Sales Quantity by Application (2018-2023) & (K Units)
Table 121. Europe Active Pharmaceutical Ingredient(API) Sales Quantity by Application (2024-2029) & (K Units)
Table 122. Europe Active Pharmaceutical Ingredient(API) Sales Quantity by Country (2018-2023) & (K Units)
Table 123. Europe Active Pharmaceutical Ingredient(API) Sales Quantity by Country (2024-2029) & (K Units)
Table 124. Europe Active Pharmaceutical Ingredient(API) Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Active Pharmaceutical Ingredient(API) Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Active Pharmaceutical Ingredient(API) Sales Quantity by Type (2018-2023) & (K Units)
Table 127. Asia-Pacific Active Pharmaceutical Ingredient(API) Sales Quantity by Type (2024-2029) & (K Units)
Table 128. Asia-Pacific Active Pharmaceutical Ingredient(API) Sales Quantity by Application (2018-2023) & (K Units)
Table 129. Asia-Pacific Active Pharmaceutical Ingredient(API) Sales Quantity by Application (2024-2029) & (K Units)
Table 130. Asia-Pacific Active Pharmaceutical Ingredient(API) Sales Quantity by Region (2018-2023) & (K Units)
Table 131. Asia-Pacific Active Pharmaceutical Ingredient(API) Sales Quantity by Region (2024-2029) & (K Units)
Table 132. Asia-Pacific Active Pharmaceutical Ingredient(API) Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Active Pharmaceutical Ingredient(API) Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Active Pharmaceutical Ingredient(API) Sales Quantity by Type (2018-2023) & (K Units)
Table 135. South America Active Pharmaceutical Ingredient(API) Sales Quantity by Type (2024-2029) & (K Units)
Table 136. South America Active Pharmaceutical Ingredient(API) Sales Quantity by Application (2018-2023) & (K Units)
Table 137. South America Active Pharmaceutical Ingredient(API) Sales Quantity by Application (2024-2029) & (K Units)
Table 138. South America Active Pharmaceutical Ingredient(API) Sales Quantity by Country (2018-2023) & (K Units)
Table 139. South America Active Pharmaceutical Ingredient(API) Sales Quantity by Country (2024-2029) & (K Units)
Table 140. South America Active Pharmaceutical Ingredient(API) Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Active Pharmaceutical Ingredient(API) Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Quantity by Type (2018-2023) & (K Units)
Table 143. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Quantity by Type (2024-2029) & (K Units)
Table 144. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Quantity by Application (2018-2023) & (K Units)
Table 145. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Quantity by Application (2024-2029) & (K Units)
Table 146. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Quantity by Region (2018-2023) & (K Units)
Table 147. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Quantity by Region (2024-2029) & (K Units)
Table 148. Middle East & Africa Active Pharmaceutical Ingredient(API) Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Active Pharmaceutical Ingredient(API) Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Active Pharmaceutical Ingredient(API) Raw Material
Table 151. Key Manufacturers of Active Pharmaceutical Ingredient(API) Raw Materials
Table 152. Active Pharmaceutical Ingredient(API) Typical Distributors
Table 153. Active Pharmaceutical Ingredient(API) Typical Customers

LIST OF FIGURES

Figure 1. Active Pharmaceutical Ingredient(API) Picture
Figure 2. Global Active Pharmaceutical Ingredient(API) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Active Pharmaceutical Ingredient(API) Consumption Value Market Share by Type in 2022
Figure 4. Generic API Examples
Figure 5. Innovative API Examples
Figure 6. Global Active Pharmaceutical Ingredient(API) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Active Pharmaceutical Ingredient(API) Consumption Value Market Share by Application in 2022
Figure 8. Oncology Examples
Figure 9. Cardiology Examples
Figure 10. Cns and Neurology Examples
Figure 11. Orthopaedic Examples
Figure 12. Pulmonology Examples
Figure 13. Gastroenterology Examples
Figure 14. Nephrology Examples
Figure 15. Ophthalmology Examples
Figure 16. Endocrinology Examples
Figure 17. Global Active Pharmaceutical Ingredient(API) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 18. Global Active Pharmaceutical Ingredient(API) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 19. Global Active Pharmaceutical Ingredient(API) Sales Quantity (2018-2029) & (K Units)
Figure 20. Global Active Pharmaceutical Ingredient(API) Average Price (2018-2029) & (US$/Unit)
Figure 21. Global Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Manufacturer in 2022
Figure 22. Global Active Pharmaceutical Ingredient(API) Consumption Value Market Share by Manufacturer in 2022
Figure 23. Producer Shipments of Active Pharmaceutical Ingredient(API) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 24. Top 3 Active Pharmaceutical Ingredient(API) Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Top 6 Active Pharmaceutical Ingredient(API) Manufacturer (Consumption Value) Market Share in 2022
Figure 26. Global Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Region (2018-2029)
Figure 27. Global Active Pharmaceutical Ingredient(API) Consumption Value Market Share by Region (2018-2029)
Figure 28. North America Active Pharmaceutical Ingredient(API) Consumption Value (2018-2029) & (USD Million)
Figure 29. Europe Active Pharmaceutical Ingredient(API) Consumption Value (2018-2029) & (USD Million)
Figure 30. Asia-Pacific Active Pharmaceutical Ingredient(API) Consumption Value (2018-2029) & (USD Million)
Figure 31. South America Active Pharmaceutical Ingredient(API) Consumption Value (2018-2029) & (USD Million)
Figure 32. Middle East & Africa Active Pharmaceutical Ingredient(API) Consumption Value (2018-2029) & (USD Million)
Figure 33. Global Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Type (2018-2029)
Figure 34. Global Active Pharmaceutical Ingredient(API) Consumption Value Market Share by Type (2018-2029)
Figure 35. Global Active Pharmaceutical Ingredient(API) Average Price by Type (2018-2029) & (US$/Unit)
Figure 36. Global Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Application (2018-2029)
Figure 37. Global Active Pharmaceutical Ingredient(API) Consumption Value Market Share by Application (2018-2029)
Figure 38. Global Active Pharmaceutical Ingredient(API) Average Price by Application (2018-2029) & (US$/Unit)
Figure 39. North America Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Type (2018-2029)
Figure 40. North America Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Application (2018-2029)
Figure 41. North America Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Country (2018-2029)
Figure 42. North America Active Pharmaceutical Ingredient(API) Consumption Value Market Share by Country (2018-2029)
Figure 43. United States Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Canada Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Mexico Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Europe Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Type (2018-2029)
Figure 47. Europe Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Application (2018-2029)
Figure 48. Europe Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Country (2018-2029)
Figure 49. Europe Active Pharmaceutical Ingredient(API) Consumption Value Market Share by Country (2018-2029)
Figure 50. Germany Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. France Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. United Kingdom Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Russia Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Italy Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Asia-Pacific Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Type (2018-2029)
Figure 56. Asia-Pacific Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Application (2018-2029)
Figure 57. Asia-Pacific Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Region (2018-2029)
Figure 58. Asia-Pacific Active Pharmaceutical Ingredient(API) Consumption Value Market Share by Region (2018-2029)
Figure 59. China Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Japan Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Korea Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. India Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Southeast Asia Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Australia Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. South America Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Type (2018-2029)
Figure 66. South America Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Application (2018-2029)
Figure 67. South America Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Country (2018-2029)
Figure 68. South America Active Pharmaceutical Ingredient(API) Consumption Value Market Share by Country (2018-2029)
Figure 69. Brazil Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Argentina Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Type (2018-2029)
Figure 72. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Application (2018-2029)
Figure 73. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Quantity Market Share by Region (2018-2029)
Figure 74. Middle East & Africa Active Pharmaceutical Ingredient(API) Consumption Value Market Share by Region (2018-2029)
Figure 75. Turkey Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Egypt Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Saudi Arabia Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. South Africa Active Pharmaceutical Ingredient(API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 79. Active Pharmaceutical Ingredient(API) Market Drivers
Figure 80. Active Pharmaceutical Ingredient(API) Market Restraints
Figure 81. Active Pharmaceutical Ingredient(API) Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient(API) in 2022
Figure 84. Manufacturing Process Analysis of Active Pharmaceutical Ingredient(API)
Figure 85. Active Pharmaceutical Ingredient(API) Industrial Chain
Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source


More Publications